{"id":800595,"date":"2026-04-07T13:26:11","date_gmt":"2026-04-07T13:26:11","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=800595"},"modified":"2026-04-07T13:26:11","modified_gmt":"2026-04-07T13:26:11","slug":"viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research_800595.html","title":{"rendered":"Viral Vector Production (Research-use) Market size to Reach USD 3.13 Billion by 2031 Driven by Expanding Gene Therapy Research"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1775564539.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Viral Vector Production (Research-use) Market size to Reach USD 3.13 Billion by 2031 Driven by Expanding Gene Therapy Research\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1775564539.jpg\" alt=\"Viral Vector Production (Research-use) Market size to Reach USD 3.13 Billion by 2031 Driven by Expanding Gene Therapy Research\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Mordor Intelligence has published a new report on the viral vector production (research-use) market, offering a comprehensive analysis of trends, growth drivers, and future projections<\/div>\n<p style=\"text-align: justify;\">Introduction<\/p>\n<p style=\"text-align: justify;\">According to Mordor Intelligence, the <a rel=\"nofollow\" class=\"Hyperlink SCXW69550699 BCX8\" href=\"https:\/\/www.mordorintelligence.com\/industry-reports\/viral-vector-production-research-use-market?utm_source=abnewswire\" rel=\"noreferrer noopener\" target=\"_blank\">viral vector production (research-use) market size<\/a> was valued at USD 1.25 billion in 2025 and is expected to grow to USD 1.46 billion in 2026, reaching USD 3.13 billion by 2031, registering a CAGR of 16.52% during the forecast period. This growth reflects the rising reliance on viral vectors in preclinical and early-stage clinical research across multiple therapeutic areas.<\/p>\n<p style=\"text-align: justify;\">The increasing number of gene therapy pipelines, with thousands of ongoing research programs, is a major factor shaping the viral vector production (research-use) market growth. Academic institutes, biotechnology firms, and pharmaceutical companies are actively investing in research-use viral vectors to support innovation.<\/p>\n<p style=\"text-align: justify;\">Key Trends in the Viral Vector Production (Research-use) Market<\/p>\n<p style=\"text-align: justify;\">Rising Demand from Gene and Cell Therapy Research<\/p>\n<p style=\"text-align: justify;\">One of the most important viral vector production (research-use) market trends is the increasing demand from gene and cell therapy research programs. Viral vectors are essential tools for delivering genetic material into cells, making them critical for early-stage research. As more therapies enter preclinical and clinical development, the demand for research-grade vectors continues to rise.<\/p>\n<p style=\"text-align: justify;\">Expansion of Contract Manufacturing Capabilities<\/p>\n<p style=\"text-align: justify;\">Another key trend in the viral vector production (research-use) market forecast is the rapid expansion of contract development and manufacturing organizations. These service providers are scaling up facilities and offering integrated solutions that include vector design, production, purification, and testing. This shift allows research organizations to focus on innovation while outsourcing complex manufacturing tasks.<\/p>\n<p style=\"text-align: justify;\">Adoption of Integrated and Automated Production Systems<\/p>\n<p style=\"text-align: justify;\">Automation and integrated production platforms are becoming more common across the viral vector production (research-use) industry. Closed systems and automated processes help reduce contamination risks and improve consistency. In addition, digital tools such as modeling and simulation are being used to optimize production workflows and improve efficiency.<\/p>\n<p style=\"text-align: justify;\">Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: <a rel=\"nofollow\" class=\"Hyperlink SCXW69550699 BCX8\" href=\"https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/viral-vector-production-research-use-market?utm_source=abnewswire\" rel=\"noreferrer noopener\" target=\"_blank\">https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/viral-vector-production-research-use-market?utm_source=abnewswire<\/a><\/p>\n<p style=\"text-align: justify;\">Viral Vector Production (Research-use) Market Segmentation<\/p>\n<p style=\"text-align: justify;\">By Vector Type<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Adeno-Associated Virus (AAV)<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Adenoviral Vectors<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Lentiviral Vectors<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Retroviral Vectors<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Other Vector Types<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">By Application<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Cell &amp; Gene Therapy Research<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Vaccine Studies<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Oncolytic Virus Research<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Other Applications<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">By End User<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Pharmaceutical &amp; Biotechnology Companies<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Contract Development &amp; Manufacturing Organizations (CDMOs)<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Academic Centers &amp; Research Institutes<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Contract Research Organizations (CROs)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">By Geography<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>North America<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Europe<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Asia-Pacific<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Middle East &amp; Africa<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>South America<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Key Players in the Viral Vector Production (Research-use) Market<\/p>\n<p style=\"text-align: justify;\">The viral vector production (research-use) market share is influenced by a mix of established global companies and specialized service providers. Market participants are focusing on expanding their capabilities through acquisitions, partnerships, and technology integration.<\/p>\n<p style=\"text-align: justify;\">Leading Companies<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Merck KGaA<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Lonza<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Thermo Fisher Scientific Inc.<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>FUJIFILM Diosynth Biotechnologies<\/p>\n<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Charles River Laboratories<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Conclusion<\/p>\n<p style=\"text-align: justify;\">The viral vector production (research-use) market forecast remains positive as demand from gene therapy and vaccine research continues to expand. The growing number of research programs and increasing collaboration between academic institutions and industry players are expected to sustain market momentum.<\/p>\n<p style=\"text-align: justify;\">At the same time, improvements in manufacturing technologies and the expansion of contract manufacturing services are helping to address existing challenges. While issues such as production complexity and raw material constraints persist, ongoing investments in innovation are expected to improve efficiency and scalability.<\/p>\n<p style=\"text-align: justify;\">Industry Related Reports<\/p>\n<p style=\"text-align: justify;\">ADC Drug CDMO Service Market:<\/p>\n<p style=\"text-align: justify;\">The market is growing due to increasing demand for targeted cancer therapies, rising outsourcing of complex drug development, and advancements in antibody-drug conjugate technologies.<\/p>\n<p style=\"text-align: justify;\">Get more insights: <a rel=\"nofollow\" class=\"Hyperlink SCXW69550699 BCX8\" href=\"https:\/\/www.mordorintelligence.com\/industry-reports\/adc-drug-cdmo-service-market?utm_source=abnewswire\" rel=\"noreferrer noopener\" target=\"_blank\">https:\/\/www.mordorintelligence.com\/industry-reports\/adc-drug-cdmo-service-market?utm_source=abnewswire<\/a><\/p>\n<p style=\"text-align: justify;\">Advanced Drug Delivery CDMO Market size:<\/p>\n<p style=\"text-align: justify;\">The market is projected to grow from USD 8.96 billion in 2026 to USD 21.06 billion by 2031 at a CAGR of 18.64%, driven by increasing demand for innovative drug delivery systems and outsourcing by pharmaceutical companies.<\/p>\n<p style=\"text-align: justify;\">Get more insights: <a rel=\"nofollow\" class=\"Hyperlink SCXW69550699 BCX8\" href=\"https:\/\/www.mordorintelligence.com\/industry-reports\/advanced-drug-delivery-cdmo-market?utm_source=abnewswire\" rel=\"noreferrer noopener\" target=\"_blank\">https:\/\/www.mordorintelligence.com\/industry-reports\/advanced-drug-delivery-cdmo-market?utm_source=abnewswire<\/a><\/p>\n<p style=\"text-align: justify;\">Inhalation CDMO Market share:<\/p>\n<p style=\"text-align: justify;\">The market is expected to expand from USD 2.41 billion in 2026 to USD 3.44 billion by 2031 at a CAGR of 7.54%, fueled by rising respiratory diseases and growing demand for inhalation-based drug delivery solutions.<\/p>\n<p style=\"text-align: justify;\">Get more insights: <a rel=\"nofollow\" class=\"Hyperlink SCXW69550699 BCX8\" href=\"https:\/\/www.mordorintelligence.com\/industry-reports\/inhalation-cdmo-market?utm_source=abnewswire\" rel=\"noreferrer noopener\" target=\"_blank\">https:\/\/www.mordorintelligence.com\/industry-reports\/inhalation-cdmo-market?utm_source=abnewswire<\/a><\/p>\n<p style=\"text-align: justify;\">About Mordor Intelligence:<\/p>\n<p style=\"text-align: justify;\">Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.<\/p>\n<p style=\"text-align: justify;\">With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace &amp; defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals &amp; materials, consumer goods &amp; services, electronics, energy &amp; power, financial services, food &amp; beverages, healthcare, hospitality &amp; tourism, information &amp; communications technology, investment opportunities, and logistics.<\/p>\n<p style=\"text-align: justify;\">For any inquiries or to access the full report, please contact:<\/p>\n<p style=\"text-align: justify;\">media@mordorintelligence.com https:\/\/www.mordorintelligence.com\/<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/mordorintelligence.com_78198.html\" rel=\"nofollow\">Mordor Intelligence Private Limited<\/a><br \/><strong>Contact Person:<\/strong> Jignesh Thakkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 617-765-2493<br \/><strong>Address:<\/strong>11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli  <br \/><strong>City:<\/strong> Hyderabad<br \/><strong>State:<\/strong> Telangana 500008<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.mordorintelligence.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.mordorintelligence.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mordor Intelligence has published a new report on the viral vector production (research-use) market, offering a comprehensive analysis of trends, growth drivers, and future projections Introduction According to Mordor Intelligence, the viral vector production (research-use) market size was valued at &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research_800595.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405],"tags":[],"class_list":["post-800595","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/800595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=800595"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/800595\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=800595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=800595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=800595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}